Stavrum Ruth, Mphahlele Matsie, Ovreås Kristi, Muthivhi Tshilidzi, Fourie P Bernard, Weyer Karin, Grewal Harleen M S
Section of Microbiology and Immunology, The Gade Institute, University of Bergen and Haukeland University Hospital, N-5021 Bergen, Norway.
J Clin Microbiol. 2009 Jun;47(6):1848-56. doi: 10.1128/JCM.02167-08. Epub 2009 Apr 22.
The reemergence of tuberculosis (TB) has become a major health problem worldwide, especially in Asia and Africa. Failure to combat this disease due to nonadherence or inappropriate drug regimens has selected for the emergence of multiple-drug-resistant (MDR) TB. The development of new molecular genotyping techniques has revealed the presence of mixed Mycobacterium tuberculosis infections, which may accelerate the emergence of drug-resistant strains. There are some studies describing the local distribution of circulating strains in South Africa, but to date, reports describing the frequency and distribution of M. tuberculosis genotypes, and specifically MDR genotypes, across the different provinces are limited. Thus, 252 isolates (of which 109 were MDR) from eight of the nine provinces of South Africa were analyzed by spoligotyping. Spoligotyping showed 10 different lineages, and ST53 (11.1%) and ST1 (10.3%) were the most frequent genotypes. Of the 75 different spoligopatterns observed, 20 (7.9%) were previously unreported. Analysis of the mycobacterial interspersed repetitive units of variable-number tandem repeats of the ST53 and ST1 isolates revealed that approximately 54% of the ST53 isolates were of mixed M. tuberculosis subpopulations. Drug resistance (defined as resistance to at least isoniazid and/or rifampin) could only be linked to a history of previous anti-TB treatment (adjusted odds ratio, 4.0; 95% confidence interval, 2.27 to 7.10; P = <0.0001). This study describes a high diversity of circulating genotypes in South Africa in addition to a high frequency of mixed M. tuberculosis subpopulations among the ST53 isolates. MDR TB in South Africa could not be attributed to the spread of any single lineage.
结核病(TB)的再度出现已成为全球主要的健康问题,尤其是在亚洲和非洲。由于不依从或不恰当的药物治疗方案而未能有效抗击这种疾病,导致了多重耐药(MDR)结核病的出现。新的分子基因分型技术的发展揭示了结核分枝杆菌混合感染的存在,这可能加速耐药菌株的出现。有一些研究描述了南非循环菌株的局部分布,但迄今为止,关于结核分枝杆菌基因型,特别是耐多药基因型在不同省份的频率和分布的报告有限。因此,对来自南非九个省份中八个省份的252株分离株(其中109株为耐多药菌株)进行了间隔寡核苷酸分型(spoligotyping)分析。间隔寡核苷酸分型显示出10种不同的谱系,ST53(11.1%)和ST1(10.3%)是最常见的基因型。在观察到的75种不同的间隔寡核苷酸分型模式中,有20种(7.9%)以前未被报道。对ST53和ST1分离株的可变数目串联重复序列的分枝杆菌插入重复单元分析表明,约54%的ST53分离株为结核分枝杆菌混合亚群。耐药性(定义为至少对异烟肼和/或利福平耐药)仅与既往抗结核治疗史有关(校正比值比为4.0;95%置信区间为2.27至7.10;P =<0.0001)。这项研究描述了南非循环基因型的高度多样性,以及ST53分离株中结核分枝杆菌混合亚群的高频率。南非的耐多药结核病不能归因于任何单一谱系的传播。